Pyrotinib in Combination With Letrozole in Patients With HER2-Positive, ER-Positive Metastatic Breast Cancer
Clinical trial NCT04407988 · UNKNOWN
Trial details
- NCT number
- NCT04407988
- Sponsor
- Hunan Cancer Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-06
- Primary completion
- 2021-12-31
- Enrollment
- 86
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.